You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription

 

Online download statistics by month:

Online download statistics by month: July 2024 to March 2026

AbstractFullPdf
Jul 202422222385
Aug 2024232232153
Sep 20241241241526
Oct 202410911378
Nov 202412612888
Dec 2024174175111
Jan 202512612983
Feb 2025290290111
Mar 2025949566
Apr 202515916193
May 2025117121102
Jun 2025505036
Jul 2025223
Nov 2025001
Mar 2026110
Total182618442536